Related Experiment Videos
Antiphospholipid antibodies do not a syndrome make
S Stone1, K Langford, C Nelson-Piercy
1Lupus Pregnancy Clinic, Guy's and St Thomas' Hospitals Trust, London, UK.
Lupus
|April 18, 2002
Summary
Antiphospholipid syndrome (APS) diagnosis can delay identifying other causes of recurrent pregnancy loss. Treating these underlying conditions, not just antithrombotic therapy, is key for successful pregnancy outcomes.
Area of Science:
- Reproductive Medicine
- Immunology
- Obstetrics
Background:
- Antiphospholipid syndrome (APS) is characterized by antiphospholipid antibodies (aPLs) and associated with poor pregnancy outcomes and thrombotic events.
- Recurrent pregnancy loss necessitates a thorough differential diagnosis beyond APS.
Observation:
- Four cases of poor pregnancy outcome were initially attributed to APS.
- Diagnosis of APS led to delayed identification of alternative etiologies for pregnancy loss.
Findings:
- Antithrombotic therapy alone did not improve pregnancy outcomes in these cases.
- Successful pregnancy outcomes were achieved after addressing other causes of recurrent miscarriage.
Implications:
- Emphasizes the importance of a comprehensive diagnostic approach in recurrent pregnancy loss.
- Highlights the need to consider and treat alternative causes of miscarriage, even in the presence of aPLs.
- Suggests that a premature APS diagnosis may impede timely management of other contributing factors.